- Home
- / Beroni Group
Beroni Group
Stock Price
$0.8
2024-10-29
Market Capitalization
$192.9 M
2024-10-29
Revenue
$638 K
FY, 2025
Beroni Group Summary
Company Summary
- Overview
- Beroni Group is an international biotechnological company. It currently has four core businesses: cell therapies, developing anti-cancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection and diagnosis of infectious diseases.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- Sydney, AU | view all locations
- Website
- https://www.beronigroup.com/
- Cybersecurity rating
Table of Contents
Key People
Hai Huang, Executive Director
Tameyuki Kawaguchi, Independent Non-Executive Director
Libing Guo, Non-Executive Director
LocationsView all
6 locations detected
Sydney, NSW HQ
Australia
401/447 Kent St
Fort Lee, NJ
United States
2083 Center Ave #3a
Kensington, NSW
Australia
Enter via gate 14 North Wing, Rupert Myers Building, Barker St
Tianjin
China
Xiqing District
Chuo City, Tokyo
Japan
1 Chome Ginza
Shinjuku City, Tokyo
Japan
Beroni Group Financials
Summary Financials
- Revenue (FY, 2025)
- $638.0K
- Gross profit (FY, 2025)
- $562.0K
- Net income (FY, 2025)
- ($4.5M)
- Cash (FY, 2025)
- $499.0K
- EBIT (FY, 2025)
- ($4.4M)
- Enterprise value
- $194.0M